SC
AMGN icon

SRB Corp’s Amgen AMGN Stock Holding History

SRB Corp’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,514
Closed -$366K – 103
2023
Q1 		$366K Sell
1,514
-55
-4% -$13.5K 0.02% 46
2022
Q4 		$412K Sell
1,569
-155
-9% -$41.5K 0.03% 89
2022
Q3 		$388K Buy
+1,724
New +$418K 0.03% 51
2021
Q2 		– Sell
-6,357
Closed -$1.58M – 83
2021
Q1 		$1.58M Buy
6,357
+2,957
+87% +$706K 0.11% 46
2020
Q4 		$782K Buy
3,400
+983
+41% +$227K 0.06% 113
2020
Q3 		$614K Buy
2,417
+296
+14% +$73.3K 0.05% 34
2020
Q2 		$501K Sell
2,121
-289
-12% -$65.9K 0.04% 106
2020
Q1 		$488K Buy
2,410
+98
+4% +$21.4K 0.05% 21
2019
Q4 		$557K Buy
2,312
+96
+4% +$21.2K 0.05% 40
2019
Q3 		$428K Sell
2,216
-587
-21% -$113K 0.04% 149
2019
Q2 		$517K Sell
2,803
-1,055
-27% -$189K 0.05% 47
2019
Q1 		$733K Buy
+3,858
New +$737K 0.07% 53

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SRB Corp's AMGN Position: Q2 2023 in Review

SRB Corp sold out of Amgen (AMGN) in Q2 2023, closing a stake of 1,514 shares — an estimated $366K sold.

SRB Corp first reported a position in AMGN in Q1 2019 and held it in 12 quarters. The position peaked at $1.58M in Q1 2021. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • SRB Corp reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • SRB Corp sold 1,514 Amgen shares in Q2 2023, an estimated $366K.
  • SRB Corp first reported a position in Amgen in Q1 2019 and held it in 12 quarters.
  • SRB Corp's Amgen position peaked at $1.58M in Q1 2021.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on SRB Corp's 13F filing for Q2 2023, filed 14 Aug 2023.